Lu Q. Le

Lu Q. Le

Auto-generated profile, based on publicly available information

Lu Q. Le

Department of Dermatology, University of Virginia, Charlottesville, United States of America

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1998 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
JLJay R. Lieberman
Jay R. Lieberman
LLLu Q. Le
Lu Q. Le
LWLilly Wu
Lilly Wu
GFGerald A. M. Finerman
Gerald A. M. Finerman
ABArnie Berk
Arnie Berk
SSSharon Stevenson
Sharon Stevenson

1 May 2001 in Immunity
Verified
Journal Article
Closed access
LLLu Q Le
Lu Q Le
JKJanusz H.S Kabarowski
Janusz H.S Kabarowski
ZWZhigang Weng
Zhigang Weng
ASAnne B Satterthwaite
Anne B Satterthwaite
ERIC HARVILLERIC HARVILL
ERIC HARVILL
OWOwen N Witte
Owen N Witte

12 February 2007 in Oncogene
Verified
Journal Article
Closed access
PDF file
LLL Q Le
L Q Le
LPL F Parada
L F Parada

1 May 2009 in Cell Stem Cell
Verified
Journal Article
Closed access
LLLu Q. Le
Lu Q. Le
TSTracey Shipman
Tracey Shipman
DBDennis K. Burns
Dennis K. Burns
LPLuis F. Parada
Luis F. Parada

21 May 2018 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CLChung-Ping Liao
Chung-Ping Liao
RBReid C. Booker
Reid C. Booker
JBJean-Philippe Brosseau
Jean-Philippe Brosseau
ZCZhiguo Chen
Zhiguo Chen
JMJuan Mo
Juan Mo
LLLu Q. Le
Lu Q. Le
Neurofibromatosis type 1 associates with multiple neoplasms, and the Schwann cell tumor neurofibroma is the most prevalent. A hallmark feature of neurofibroma is mast cell infiltration, which is recruited by chemoattractant stem cell factor (SCF) and has been suggested to sustain neurofibroma tumorigenesis. In the present study, we use new, genetically engineered Scf mice to decipher the contributions of tumor-derived SCF and mast cells to neurofibroma development. We demonstrate that mast cell infiltration is dependent on SCF from tumor Schwann cells. However, removal of mast cells by depleting the main SCF source only slightly affects neurofibroma progression. Other inflammation signatures show that all neurofibromas are associated with high levels of macrophages regardless of Scf status. These findings suggest an active inflammation in neurofibromas and partly explain why mast cell removal alone is not sufficient to relieve tumor burden in this experimental neurofibroma model. Furthermore, we show that plexiform neurofibromas are highly associated with injury-prone spinal nerves that are close to flexible vertebras. In summary, our study details the role of inflammation in neurofibromagenesis. Our data indicate that prevention of inflammation and possibly also nerve injury at the observed tumor locations are therapeutic approaches for neurofibroma prophylaxis and that such treatment should be explored.

5 December 2008 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
AGAnand K. Ganesan
Anand K. Ganesan
HHHsiang Ho
Hsiang Ho
BBBrian Bodemann
Brian Bodemann
SPSean Petersen
Sean Petersen
JAJayavani Aruri
Jayavani Aruri
MWMichael A. White
Michael A. White
Melanin protects the skin and eyes from the harmful effects of UV irradiation, protects neural cells from toxic insults, and is required for sound conduction in the inner ear. Aberrant regulation of melanogenesis underlies skin disorders (melasma and vitiligo), neurologic disorders (Parkinson's disease), auditory disorders (Waardenburg's syndrome), and opthalmologic disorders (age related macular degeneration). Much of the core synthetic machinery driving melanin production has been identified; however, the spectrum of gene products participating in melanogenesis in different physiological niches is poorly understood. Functional genomics based on RNA-mediated interference (RNAi) provides the opportunity to derive unbiased comprehensive collections of pharmaceutically tractable single gene targets supporting melanin production. In this study, we have combined a high-throughput, cell-based, one-well/one-gene screening platform with a genome-wide arrayed synthetic library of chemically synthesized, small interfering RNAs to identify novel biological pathways that govern melanin biogenesis in human melanocytes. Ninety-two novel genes that support pigment production were identified with a low false discovery rate. Secondary validation and preliminary mechanistic studies identified a large panel of targets that converge on tyrosinase expression and stability. Small molecule inhibition of a family of gene products in this class was sufficient to impair chronic tyrosinase expression in pigmented melanoma cells and UV-induced tyrosinase expression in primary melanocytes. Isolation of molecular machinery known to support autophagosome biosynthesis from this screen, together with in vitro and in vivo validation, exposed a close functional relationship between melanogenesis and autophagy. In summary, these studies illustrate the power of RNAi-based functional genomics to identify novel genes, pathways, and pharmacologic agents that impact a biological phenotype and operate outside of preconceived mechanistic relationships. Aberrant pigment regulation correlates with skin disorders, opthalmologic disorders, and neurologic disorders. While extensive studies have identified regulators of mouse coat color, the regulation of human skin phenotypic variation is less well understood. To give a broader picture of the molecular regulators of melanogenesis in human cells, we used a genome-wide siRNA functional genomics approach to identify 92 novel regulators of melanin production in heavily pigmented MNT-1 melanoma cells. Our screen identified several genes that converge to regulate tyrosinase, the rate-limiting step in pigment production, in both MNT-1 cells and primary melanocytes. Some of the identified genes were selectively active in different genetic backgrounds, suggesting that they may regulate human phenotypic variation. Small molecule inhibition of a family of novel pigment regulators was sufficient to impair pigment production in melanocytes. Additionally, our screen identified molecular machinery known to support autophagosome biosynthesis as putative regulators of melanogenesis. In vitro co-localization studies and autophagy-deficient mice provided evidence that normal melanogenesis requires the same molecular machinery used by the autophagy pathway. Taken together, these results illustrate the utility of genome wide siRNA screening approaches for identifying genes, novel pharmacologic agents, and pathways that regulate differentiated cellular phenotypes.